Chimerism does not predict for outcome after alemtuzumab based conditioning
Authors:
Open Access
- 14 May 2007
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 40 (2) , 181
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemiaBone Marrow Transplantation, 2007
- Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2006
- Prognostic significance of WT-1 levels in patients with myelodysplastic syndrome and leukemia after reduced-intensity allogeneic transplantationJournal of Clinical Oncology, 2006
- Fludarabine, Melphalan, and Alemtuzumab Conditioning in Adults With Standard-Risk Advanced Acute Myeloid Leukemia and Myelodysplastic SyndromeJournal of Clinical Oncology, 2005
- Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamideBlood, 2005